Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new history entry on 2026-03-24 for Study Status. The 2026-03-23 entry shows 56 changes, and the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded a new Revision: v3.5.0 entry and removed Revision: v3.4.3 from the history.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe latest revision (v3.4.3, 2026-02-27) adds Contacts/Locations and Study Status; the prior revision (v3.4.2, 2026-01-20) was deleted.SummaryDifference0.3%

- Check53 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2 on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a new revision entry v3.4.1 and removed v3.4.0 from the record history. This update keeps the historical record current and accurate.SummaryDifference0.1%

- Check68 days agoChange DetectedGlossary display option added; color-coded indicators explain changes with green for additions and red for deletions, and the page shows an updated revision note (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.